Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.
Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.
BRUKER CORP (BRKR) reported that officer Juergen Srega, President CALID, received equity awards. He was granted 16,898 shares of common stock in the form of Restricted Stock Units, which vest in four equal annual installments starting on the first anniversary of the August 15, 2026 grant date, increasing his directly held common shares to 174,625. He was also granted a stock option for 13,698 shares of common stock at an exercise price of $57.70 per share, vesting in four equal annual installments from the same grant date, exercisable from August 15, 2027 until August 15, 2036.
BRUKER CORP (BRKR) reported equity awards and related tax withholding for President & CEO Frank H. Laukien. On August 15, 2026, he received a grant of 71,651 stock options with an exercise price of $63.47 per share, vesting in four equal annual installments starting on the first anniversary of the grant date. He also received 29,463 Restricted Stock Units, which vest in four equal annual installments on the same schedule. On that date, 4,760 common shares were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted RSUs. Indirect holdings include 336,607 common shares held by a daughter.
BRUKER CORP (BRKR) reported equity compensation transactions for Executive Vice President and CFO Gerald N. Herman on August 15, 2026. He received 15,794 shares of Common Stock as Restricted Stock Units that vest in four equal annual installments starting one year after the grant date, and a stock option for 12,803 shares of Common Stock at an exercise price of $63.47 per share, also vesting in four equal annual installments. The option expires on August 15, 2036. On the same date, 2,724 shares of Common Stock were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted restricted stock units.
BRUKER CORP (BRKR) reported multiple equity compensation and trading transactions by executive vice president Mark Munch. On August 15, 2026, he received a grant of 11,708 stock options with an exercise price of $57.70 per share, vesting in four equal annual installments, and a grant of 14,443 Restricted Stock Units that also vest in four equal annual installments. That same day, 2,984 shares of common stock were withheld by the company to satisfy tax obligations upon vesting of previously granted RSUs. On August 14, 2026, he exercised 2,000 stock options at $22.19 per share, received 2,000 shares of common stock, and sold 2,000 shares at $57.60 per share pursuant to a Rule 10b5-1 trading plan.
Bruker Corporation has a holder planning to sell 3,473 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $197,613.70, to be sold on or after August 17, 2026 on NASDAQ.
The same holder reports prior sales of restricted common stock back to the issuer in the past three months, including 847 shares on August 9, 2026, 565 shares on August 10, 2026, 605 shares on August 11, 2026, and 1,456 shares on August 15, 2026.
Mark R. Munch filed a Form 144 indicating a plan to sell 2,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $115,200.00 as of August 14, 2026. The planned sale is related to a stock option exercise for cash. Over the prior three months, Mark R. Munch reported selling 2,000 shares of common stock on each of May 15, June 15, and July 15, 2026, for aggregate prices of $87,800.00, $109,520.00, and $120,500.00, respectively.
Bruker Corporation announced that its Board of Directors has declared a quarterly cash dividend on its common stock, $0.01 par value per share, of $0.05 per share. The dividend was declared on August 14, 2026 and is payable on October 7, 2026 to shareholders of record at the close of business on September 21, 2026.
BRUKER CORP executive Mark Munch, Executive Vice President and President of Bruker Nano Inc., reported a Form 4 transaction involving company common stock. On 2026-08-11, 1,619 shares of common stock were withheld by the company at $57.02 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. Following this tax-withholding disposition, Munch directly holds 123,347 shares of BRUKER CORP common stock.
BRUKER CORP executive vice president and CFO Gerald N. Herman reported a Code F transaction involving 1,410 shares of common stock on 2026-08-11. According to the company’s disclosure, these shares were withheld to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, rather than sold in an open-market transaction. Following this tax-withholding disposition, Herman’s directly held ownership stands at 98,284 shares of BRUKER CORP common stock.
BRUKER CORP President & CEO Frank H. Laukien reported a Form 4 reflecting a code F transaction in the company’s common stock. On 2026-08-11, 4,838 shares were withheld by the company at $57.02 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. After this withholding, Laukien directly holds 38,482,340 common shares. The filing also lists various indirect holdings for family members, including 336,607 shares held indirectly “By Daughter.”